Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Current Leases: 2015-2020

Historic Current Leases for Outlook Therapeutics (OTLK) over the last 4 years, with Jun 2020 value amounting to $181,585.

  • Outlook Therapeutics' Current Leases fell 11.60% to $181,585 in Q2 2020 from the same period last year, while for Jun 2020 it was $181,585, marking a year-over-year decrease of 11.60%. This contributed to the annual value of $192,290 for FY2019, which is 63.08% down from last year.
  • As of Q2 2020, Outlook Therapeutics' Current Leases stood at $181,585, which was up 3.26% from $175,853 recorded in Q1 2020.
  • In the past 5 years, Outlook Therapeutics' Current Leases registered a high of $1.0 million during Q4 2016, and its lowest value of $107,600 during Q4 2017.
  • For the 3-year period, Outlook Therapeutics' Current Leases averaged around $355,931, with its median value being $211,681 (2019).
  • Its Current Leases has fluctuated over the past 5 years, first slumped by 89.39% in 2017, then spiked by 218.50% in 2018.
  • Quarterly analysis of 5 years shows Outlook Therapeutics' Current Leases stood at $1.0 million in 2016, then crashed by 89.39% to $107,600 in 2017, then spiked by 218.50% to $342,706 in 2018, then plummeted by 49.63% to $172,609 in 2019, then declined by 11.60% to $181,585 in 2020.
  • Its Current Leases stands at $181,585 for Q2 2020, versus $175,853 for Q1 2020 and $172,609 for Q4 2019.